Metabolomics - The Online Scientific Community

Bruker Installs NMR Metabolic Profiling Systems at NTNU Trondheim for Research on Cancer Diagnostics and Treatment
Wednesday, February 16, 2011
Researchers will use the NMR instrumentation for rapid, high-throughput analyses, aiming for characterization, treatment planning and monitoring of cancer patients.

BD Launches World’s Smallest Pen Needle
Friday, February 11, 2011
BD announces the launch of BD Micro-Fine™+ 4mm pen needle - the world’s smallest pen needle. This needle is proven to be as effective as longer needles for patients of all body types and proven to offer a less painful injection experience for the estimated 800,000 people in the UK with diabetes using injectable therapies.

Highly Efficient, Reproducible Non-Cytotoxic Transfection Reagent
Saturday, January 15, 2011
GenePORTER® Gold from AMSBIO is a reproducible lipid-based reagent for effective transfection of a wide variety of cell lines.

Sera Lab Launches Extensive Microsome and S9 Fraction Range for Drug Metabolism Studies
Thursday, December 09, 2010
Broad range of liver microsomes enables advanced drug development research.

Biotivia Release Resveratrol Related Supplement, Pteromax
Friday, December 03, 2010
Research studies of pterostilbene have shown stronger effects in the reduction of cholesterol and improvement of cognitive function.

Agilent Technologies Expands Bioinformatics System into Integrated Biology Suite
Tuesday, November 23, 2010
New GeneSpring GX 11.5 has been expanded to interpret exon microarray, proteomics and metabolomics experiments together.

Chemically Intelligent Small Molecule Structural Elucidation Software for Mass Spectrometry
Wednesday, November 17, 2010
Thermo Fisher Scientific Inc. have announced Mass Frontier 7.0, the newest release of its small molecule structural elucidation software. The software simplifies the management, evaluation and interpretation of mass spectral data and can be used for metabolism, metabolomics, forensics, natural products, impurities and degradants research.

CeGaT Offers Fast and Cost Efficient Genetic Screening Via Next-Generation Sequencing
Monday, November 15, 2010
Company offers 28 panels for nearly 400 genes as screening tool to test for genes involved in various diseases.

ALMSCO International Launches TargetView Software for Analysis of Target Compounds in Complex GC/MS Data
Wednesday, November 10, 2010
The software will benefit GC/MS users in environmental monitoring, forensic science and testing chemical emissions from consumer goods.

<<	2 3 4 5 6 7 8	>>
Showing Results 41 - 50 of 298

Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.

FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.

Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.